Ironwood Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Ironwood Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Ironwood Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Ironwood Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Ironwood Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Ironwood Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Thomas McCourt
Chief Executive Officer; Director Executive BoardMr. Thomas McCourt has been the Chief Executive Officer and Director of the company since 2021. Prior to this, he served as the President and Interim Chief Executive Officer of the company from March 2021 to June 2021. Previously, he served as the President of the company from April 2019 to June 2021. He also served as the Senior Vice President and Chief Commercial Officer of the company since 2009. He has served in various leadership roles in Amgen Inc., Novartis AG, Astra-Merck Inc., and Acceleron Pharma Inc.
Julie H. McHugh
Chairperson Executive BoardMs. Julie H. McHugh has been the Chairperson of the company since 2019. Prior to this, she served as the Chief Operating Officer of Endo Health Solutions Inc from 2010 to 2013. Ms. McHugh also served as the Chief Executive Officer of Nora Therapeutics Inc, Chairperson for the worldwide virology business unit of Johnson & Johnson, and President of Centocor Inc.
Gregory Martini
Chief Financial Officer; Senior Vice President Senior ManagementMr. Gregory Martini has been the Senior Vice President and Chief Financial Officer of the company since January 2025. Prior to this, he served as Vice President of Strategic Finance and Investor Relations; and Senior Director of Financial Planning and Analysis for the company. Mr. Martini has also served with Thermo Fisher Scientific, Ernst & Young LLP, and Raytheon.
Jeff Ruberti
Chief Strategy Officer Senior ManagementMr. Jeff Ruberti has been the Chief Strategy Officer of the company since 2025. Prior to this, he served as Vice President of Corporate Development for the company. Previously, he served in various corporate development and strategy roles at Steward Health Care System and Ernst & Young
Jeffrey Silber
Head - Research and Drug Development; Chief Medical Officer Senior ManagementMr. Jeffrey Silber has been the Chief Medical Officer and Head of Research and Drug Development of the company since July 2026. Previously, he served as Chief Medical Officer of Vedanta Biosciences. Prior to this, he served as Senior Vice President in Clinical Development and Head of Development Sciences at EMD Serono. Prior to that, he served as Vice President and Head of Strategic Portfolio Development at AbbVie. He also worked as Vice President and Therapeutic Area Head at Vaccine Clinical Research.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer